Labeler
Dr. Reddy's Laboratories Inc. NDC Codes
Dr. Reddy's Laboratories Inc. lists 301 finished drug products in the FDA NDC Directory under NDC labeler codes 43598, 55741, 75907.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Methylphenidate Hydrochloride (LA), pomalidomide, eltrombopag, Metoprolol succinate, Nilotinib, Triamcinolone Acetonide, Phenylephrine Hydrochloride, Sacubitril and Valsartan Sacubitril and Valsartan, Esomeprazole Magnesium, Omeprazole and Sodium Bicarbonate, Carbidopa and Levodopa, Sugammadex, Acetaminophen Extra Strength, Nintedanib, Pralatrexate
- Active ingredients
- Acetaminophen, Nicotine, Methylphenidate hydrochloride, Pomalidomide, Eltrombopag olamine, Metoprolol succinate, Omeprazole, Sodium bicarbonate, Nilotinib hydrochloride monohydrate, Triamcinolone acetonide, Phenylephrine hydrochloride, Sacubitril
- NDC labeler codes
- 43598, 55741, 75907
- Strengths (from the 100 most recently listed products)
- Omeprazole 20 mg/1; Sodium bicarbonate 1680 mg/1; Acetaminophen 500 mg/1; Nicotine 4 mg/1; Nicotine 2 mg/1; Esomeprazole magnesium 20 mg/1; Acetaminophen 250 mg/1; Phenylephrine hydrochloride 25 mg/mL; Doxorubicin hydrochloride 2 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Carbidopa 25 mg/1; Levodopa 100 mg/1; Diphenhydramine 25 mg/1; Caffeine 65 mg/1; Aspirin 250 mg/1; Pomalidomide 4 mg/1; Pomalidomide 3 mg/1; Pomalidomide 2 mg/1; Pomalidomide 1 mg/1; Permethrin 50 mg/100g
- Dosage forms
- Tablet, Capsule, Tablet, Film coated, Injection, Solution, Injection, Gum, Chewing, Capsule, Extended release, Tablet, Film coated, Extended release, Kit, Solution/ drops, Powder, For suspension, Tablet, Coated, Injection, Powder, Lyophilized, For solution, Solution, Capsule, Liquid filled, Injection, Suspension, Capsule, Delayed release, Cream, Injection, Suspension, Liposomal, Tablet, Extended release
- Routes
- Oral, Intravenous, Intramuscular, Ophthalmic, Intra-articular, Topical, Subcutaneous, Respiratory (Inhalation), Buccal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Proton Pump Inhibitor, Kinase Inhibitor, Cholinergic Nicotinic Agonist, Nonsteroidal Anti-inflammatory Drug, Thalidomide Analog, Thrombopoietin Receptor Agonist, beta-Adrenergic Blocker, alpha-1 Adrenergic Agonist, Corticosteroid, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Aromatic Amino Acid, Histamine-1 Receptor Antagonist, Folate Analog Metabolic Inhibitor, Serotonin Reuptake Inhibitor, Iron Chelator, Nucleoside Metabolic Inhibitor, Anthracycline Topoisomerase Inhibitor, P2Y12 Platelet Inhibitor, beta2-Adrenergic Agonist, Phenothiazine, Calcineurin Inhibitor Immunosuppressant, HMG-CoA Reductase Inhibitor, Methylxanthine, Platelet Aggregation Inhibitor, Pyrethroid, Substance P/Neurokinin-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Vasodilator, Amphetamine Anorectic, Antifibrinolytic Agent, Tetracycline-class Drug, Catecholamine Synthesis Inhibitor, Factor Xa Inhibitor, Blood Coagulation Factor, Phosphate Binder, Antiparasitic, Pediculicide, Benzodiazepine, Calcitonin
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 163 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | TabletOral | 43598-101 | 43598-0101-0543598-0101-7843598-0101-87+1 more | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | TabletOral | 43598-103 | 43598-0103-0543598-0103-8143598-0103-87+1 more | — |
| Neconnorethindrone and ethinyl estradiol | — | KitOral | 75907-085 | 75907-0085-2875907-0085-32 | — |
| Famotidine | Famotidine 40 mg/5mL | For suspensionOral | 43598-572 | 43598-0572-11 | — |
| Carboprost Tromethamine | Carboprost tromethamine 250 ug/mL | Injection, SolutionIntramuscular | 43598-179 | 43598-0179-10 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | Injection, SolutionIntramuscular | 43598-262 | 43598-0262-23 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 10 mg/1 | CapsuleOral | 75907-069 | 75907-0069-0175907-0069-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 25 mg/1 | CapsuleOral | 75907-070 | 75907-0070-0175907-0070-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 50 mg/1 | CapsuleOral | 75907-071 | 75907-0071-0175907-0071-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 75 mg/1 | CapsuleOral | 75907-072 | 75907-0072-01 | — |
| Plerixafor | Plerixafor 24 mg/1.2mL | SolutionSubcutaneous | 43598-308 | 43598-0308-23 | — |
| Zoledronic Acid | Zoledronic acid 4 mg/5mL | Injection, Solution, ConcentrateIntravenous | 43598-233 | 43598-0233-11 | — |
| Guaifenesin and Dextromethorphan HBR | Guaifenesin 600 mg/1; Dextromethorphan hydrobromide 30 mg/1 | Tablet, Extended releaseOral | 43598-114 | 43598-0114-0143598-0114-2043598-0114-40 | — |
| Guaifenesin and Dextromethorphan HBR | Guaifenesin 600 mg/1; Dextromethorphan hydrobromide 30 mg/1 | Tablet, Extended releaseOral | 43598-231 | 43598-0231-01 | — |
| Guaifenesin and Dextromethorphan HBR | Guaifenesin 1200 mg/1; Dextromethorphan hydrobromide 60 mg/1 | Tablet, Extended releaseOral | 43598-232 | 43598-0232-37 | — |
| Regadenoson | Regadenoson anhydrous .08 mg/mL | InjectionIntravenous | 43598-616 | 43598-0616-11 | — |
| Icosapent Ethyl | Icosapent ethyl 500 mg/1 | CapsuleOral | 43598-746 | 43598-0746-72 | — |
| Thiamine Hydrochloride | Thiamine hydrochloride 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | 43598-050 | 43598-0050-25 | — |
| Sterile Diluent for Treprostinilwater | Water 1 mL/mL | Injection, SolutionIntravenous | 43598-126 | 43598-0126-11 | — |
| Treprostinil | Treprostinil 50 mg/20mL | Injection, SolutionIntravenous, Subcutaneous | 43598-646 | 43598-0646-11 | — |
| Treprostinil | Treprostinil 100 mg/20mL | Injection, SolutionIntravenous, Subcutaneous | 43598-647 | 43598-0647-11 | — |
| Treprostinil | Treprostinil 200 mg/20mL | Injection, SolutionIntravenous, Subcutaneous | 43598-648 | 43598-0648-11 | — |
| Treprostinil | Treprostinil 20 mg/20mL | Injection, SolutionIntravenous, Subcutaneous | 43598-649 | 43598-0649-11 | — |
| Nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 43598-142 | 43598-0142-0643598-0142-11 | — |
| Lubiprostone | Lubiprostone 8 ug/1 | Capsule, Gelatin coatedOral | 43598-163 | 43598-0163-60 | — |
| Lubiprostone | Lubiprostone 24 ug/1 | Capsule, Gelatin coatedOral | 43598-168 | 43598-0168-60 | — |
| Difluprednate Ophthalmic Emulsiondifluprednate ophthalmic | Difluprednate .5 mg/mL | EmulsionOphthalmic | 43598-588 | 43598-0588-11 | — |
| Biorphenphenylephrine hydrochloride | Phenylephrine hydrochloride .1 mg/mL | Injection, SolutionIntravenous | 43598-172 | 43598-0172-1543598-0172-25 | — |
| Biorphenphenylephrine hydrochloride | Phenylephrine hydrochloride 10 mg/mL | Injection, SolutionIntravenous | 43598-199 | 43598-0199-10 | — |
| Timolol Maleate Ophthalmic Gel Forming Solution 0.5% | Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 43598-748 | 43598-0748-11 | — |
| Thiotepa | Thiotepa 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntracavitary, Intravenous, Intravesical | 43598-171 | 43598-0171-11 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 400 mg/1 | Tablet, Film coatedOral | 43598-131 | 43598-0131-0143598-0131-05 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 300 mg/1 | Tablet, Film coatedOral | 43598-132 | 43598-0132-0143598-0132-05 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 100 mg/1 | Tablet, Film coatedOral | 43598-133 | 43598-0133-0143598-0133-05 | — |
| Chlorthalidone | Chlorthalidone 50 mg/1 | TabletOral | 43598-167 | 43598-0167-0143598-0167-10 | — |
| Chlorthalidone | Chlorthalidone 25 mg/1 | TabletOral | 43598-170 | 43598-0170-0143598-0170-10 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 43598-285 | 43598-0285-3043598-0285-3143598-0285-70 | — |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | 43598-161 | 43598-0161-3343598-0161-52 | — |
| Desmopressin Acetate | Desmopressin acetate 4 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 43598-053 | 43598-0053-11 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 43598-511 | 43598-0511-0143598-0511-63 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 43598-512 | 43598-0512-0143598-0512-63 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 43598-513 | 43598-0513-0143598-0513-21 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 43598-514 | 43598-0514-0143598-0514-21 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 43598-515 | 43598-0515-0143598-0515-21 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 43598-516 | 43598-0516-0143598-0516-63 | — |
| Guaifenesin 1200 mgguaifenesin | Guaifenesin 1200 mg/1 | Tablet, Extended releaseOral | 43598-108 | 43598-0108-37 | — |
| Guaifenesin 600 mgguaifenesin | Guaifenesin 600 mg/1 | Tablet, Extended releaseOral | 43598-110 | 43598-0110-01 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 10 mg/1 | TabletOral | 43598-830 | 43598-0830-0543598-0830-7843598-0830-90 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 20 mg/1 | TabletOral | 43598-831 | 43598-0831-0543598-0831-7843598-0831-90 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | TabletOral | 43598-832 | 43598-0832-0543598-0832-7843598-0832-90 | — |
Dr. Reddy's Laboratories Inc.: common questions
- What is Dr. Reddy's Laboratories Inc.'s NDC labeler code?
- 43598, 55741, 75907. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Dr. Reddy's Laboratories Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.